Editorial

5 Breakthroughs Now Revolutionizing Drug Development
Editorial 5 Breakthroughs Now Revolutionizing Drug Development

Technology and science are constantly evolving and advancing, and with them, the world of drug development is also changing. Using AI and CRISPR for gene editing and bioprinting human-like tissues are just some examples of innovations that are set to change how life-saving therapies are developed.

Gene Therapy is Here to Change Everything
Editorial Gene Therapy is Here to Change Everything

The biopharmaceutical industry is undergoing rapid transformation due to the rising popularity of cell and gene therapy for various cancer conditions, some uncommon diseases, and degenerative conditions, as traditional drugs and biological products show limited success. The field is now moving to

2025 Biotech Survival Guide: The 5 Key Threats You Can’t Ignore
Editorial 2025 Biotech Survival Guide: The 5 Key Threats You Can’t Ignore

The biotech industry in particular will experience high levels of uncertainty and changes in 2025. Emerging biotech companies are facing significant challenges due to new technologies, intense global competition, and changes in the market. Next year, 2025, may be tough for startups as they

Building the Future: Why Biopharma Campuses Must Evolve
Editorial Building the Future: Why Biopharma Campuses Must Evolve

The life sciences industry has come a long way since the last COVID-19 outbreak. Today, organizations are prioritizing efficiency, speed, and innovation. That’s why biopharma and biotech companies are increasingly broadening their investments in physical spaces. Campuses and facilities are being

Disruption on the Horizon: How BCIs Can Change the Course of Biopharma
Editorial Disruption on the Horizon: How BCIs Can Change the Course of Biopharma

The global brain-computer interface (BCI) market is expected to grow from USD $2.1 million in 2022 to USD $9.4 million by 2032, with a growth rate of 16.7% from 2023 to 2032. This exciting area of research and development can create a direct communication link between the human brain and devices

Will AI-Driven Collaboration Redefine Drug Development?
Editorial Will AI-Driven Collaboration Redefine Drug Development?

In an era when speed, accuracy, and efficiency are critical, the biopharma industry stands on the verge of a huge transformation. Artificial intelligence (AI) is moving beyond just a mere buzzword; it is fast becoming an important factor in how drugs are discovered, developed, and marketed. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later